Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

Presentation TCT 2024

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

Presenter: Michael Joner

October 29, 2024

Presentation TCT 2023

Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free

Presenter: Stephan Windecker

October 26, 2023

Presentation TCT 2023

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

Presenter: Kirstine Hansen

October 25, 2023

Presentation TCT 2020

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

Presenter: Markus Krackhardt

October 14, 2020

Presentation TCT 2020

TCT 267: BIOVITESSE – Multicenter Prospective First-In-Man Study of a New Polymer Free Drug-coated Stent With Ultrathin Struts: Clinical Study Outcome

Presenter: Lorenz Raber

October 14, 2020

Presentation TCT 2019

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Polymer-Free DES: Lessons Learned From Recent Trials

Presenter: Michael Maeng

September 26, 2019

Presentation TCT 2019

TCT 42: Polymer-free Drug-coated vs. Bare-metal Coronary Stents in Patients Undergoing Non-cardiac Surgery A Subgroup Analysis of the LEADERS FREE Trial

Presenter: Abdelhakim Allali

September 25, 2019

Presentation TCT Abstracts Posters 2018

Intrapatient randomised study with polymer free DES vs. abluminal biodegradable polymer DES with early OCT follow-up

Presenter: Imanol Otaegui

September 25, 2018

Presentation TCT 2018

SORT OUT IX: A Randomized Trial Comparing a Polymer-Free Coronary Drug-Eluting Stent With an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent in an All-Comers Patient Population

Presenter: Sunil V. Rao, Lisette Okkels Jensen

September 22, 2018

Presentation TCT 2018

LEADERS FREE II: Evaluation of a Polymer-Free Coronary Drug-Eluting Stent in High Bleeding-Risk Patients With One-Month Dual Antiplatelet Therapy

Presenter: Mitchell W. Krucoff

September 22, 2018

Presentation TCT 2018

ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent in an All-Comers Patient Population

Presenter: Gregg W. Stone, Pieter R. Stella

September 22, 2018

Presentation Cardiovascular Interventions 2017

Durable Polymer and Polymer-Free DES

Presenter: Ajay J. Kirtane, MD

November 10, 2017

Presentation TCT 2017

Cre8: Novel Attributes and Clinical Trial Program Update

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Alaide Chieffo

November 01, 2017

Presentation TCT 2017

Yukon and Coroflex ISAR Polymer-Free DES: Clinical Outcomes and Future Directions

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Robert A. Byrne

November 01, 2017

Presentation TCT 2017

BioFreedom: LEADERS FREE Long-term Results and LEADERS FREE II Design

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Philip M. Urban

November 01, 2017

Presentation TCT 2017

Polymer-Free Drug-Filled Stent and Updated REVELUTION Results

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Stephen G. Worthley

November 01, 2017

Presentation TCT 2017

Defining the High Bleeding Risk Patient: Consensus and Knowledge Gaps

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Marie-Claude Morice

November 01, 2017

Presentation TCT 2017

Theoretical Beneficial Effects of Eliminating the Polymer From DES: From Mechanical Issues to Biocompatibility

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Renu Virmani

November 01, 2017

Presentation TCT 2017

RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease

Presenter: David P. Faxon, Joseph A. Hill, Ling Tao

October 31, 2017

Advertisement

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

TCT 267: BIOVITESSE – Multicenter Prospective First-In-Man Study of a New Polymer Free Drug-coated Stent With Ultrathin Struts: Clinical Study Outcome

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Polymer-Free DES: Lessons Learned From Recent Trials

TCT 42: Polymer-free Drug-coated vs. Bare-metal Coronary Stents in Patients Undergoing Non-cardiac Surgery A Subgroup Analysis of the LEADERS FREE Trial

Intrapatient randomised study with polymer free DES vs. abluminal biodegradable polymer DES with early OCT follow-up

SORT OUT IX: A Randomized Trial Comparing a Polymer-Free Coronary Drug-Eluting Stent With an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent in an All-Comers Patient Population

LEADERS FREE II: Evaluation of a Polymer-Free Coronary Drug-Eluting Stent in High Bleeding-Risk Patients With One-Month Dual Antiplatelet Therapy

ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent in an All-Comers Patient Population

Durable Polymer and Polymer-Free DES

Cre8: Novel Attributes and Clinical Trial Program Update

Yukon and Coroflex ISAR Polymer-Free DES: Clinical Outcomes and Future Directions

BioFreedom: LEADERS FREE Long-term Results and LEADERS FREE II Design

Polymer-Free Drug-Filled Stent and Updated REVELUTION Results

Defining the High Bleeding Risk Patient: Consensus and Knowledge Gaps

Theoretical Beneficial Effects of Eliminating the Polymer From DES: From Mechanical Issues to Biocompatibility

RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content